FIELD: chemistry; pharmaceutics.
SUBSTANCE: group of inventions relates to chemical and pharmaceutical industry, namely to a liquid dosage form for oral administration for the treatment and prevention of flu and ARVI. The liquid dosage form for oral administration for the treatment and prevention of flu and ARVI contains 2-(imidazole-4-yl)ethanamide of pentanedioic-1,5 acid or its pharmaceutically acceptable salt in the effective amount and pharmaceutically acceptable auxiliary substances, while pH of the liquid dosage form is from 3 to 8. The use of a liquid dosage form for the treatment and/or prevention of flu and ARVI is also described.
EFFECT: proposed liquid form based on 2-(imidazole-4-yl)ethanamide of pentanedioic-1,5 acid is stable.
14 cl, 33 tbl, 6 ex
